Adagio Therapeutics (NASDAQ:ADGI) has named interim chief executive officer and chief operating officer David Hering, as company’s permanent CEO and a director on the board. “As COVID-19 continues to ...
Source LinkAdagio Therapeutics (NASDAQ:ADGI) has named interim chief executive officer and chief operating officer David Hering, as company’s permanent CEO and a director on the board. “As COVID-19 continues to ...
Source Link
Comments